New Strong Buy Stocks for November 12th

Zacks
12 Nov 2024

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Grupo Financiero Galicia S.A. GGAL: This financial service holding company has seen the Zacks Consensus Estimate for its current year earnings increasing 8.4% over the last 60 days.

Grupo Financiero Galicia S.A. Price and Consensus

Grupo Financiero Galicia S.A. price-consensus-chart | Grupo Financiero Galicia S.A. Quote

Gold Fields Limited GFI: This gold mining company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.8% over the last 60 days.

Gold Fields Limited Price and Consensus

Gold Fields Limited price-consensus-chart | Gold Fields Limited Quote

Fulcrum Therapeutics, Inc. FULC: This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 39.1% over the last 60 days.

Fulcrum Therapeutics, Inc. Price and Consensus

Fulcrum Therapeutics, Inc. price-consensus-chart | Fulcrum Therapeutics, Inc. Quote

Deckers Outdoor Corporation DECK: This footwear and apparel company has seen the Zacks Consensus Estimate for its current year earnings increasing 4% over the last 60 days.

Deckers Outdoor Corporation Price and Consensus

Deckers Outdoor Corporation price-consensus-chart | Deckers Outdoor Corporation Quote

New Gold Inc. NGD: This gold mining company has seen the Zacks Consensus Estimate for its current year earnings increasing 30.8% over the last 60 days.

New Gold Inc. Price and Consensus

New Gold Inc. price-consensus-chart | New Gold Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Deckers Outdoor Corporation (DECK) : Free Stock Analysis Report

Gold Fields Limited (GFI) : Free Stock Analysis Report

New Gold Inc. (NGD) : Free Stock Analysis Report

Grupo Financiero Galicia S.A. (GGAL) : Free Stock Analysis Report

Fulcrum Therapeutics, Inc. (FULC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10